TGFB1 and chronic kidney disease: The TGF-β/Smad signaling pathway exerts an important effect on renal fibrosis, while targeting the TGF-β/Smad3 signaling pathway may represent an effective treatment approach for CKD treatment that is associated with renal fibrosis.14